Falk Wachowius

My research interests lie primarily in the area of nucleic acid biochemistry, with a present focus on nucleic acid-based therapeutics. I am currently mainly dedicated to the development of oligonucleotides that target SARS-CoV-2 (sub)genomic RNA to inhibit virus replication.
I performed my masters in biochemistry at the University of Greifswald and Marseille and received my PhD in chemistry from the MPI for Biophysical Chemistry in Göttingen. Before joining the vascular nephrology group I hold research positions at the MRC-LMB in Cambridge and the University of Groningen.